What is Outlook Therapeutics Inc's P/S Ratio?

Outlook Therapeutics Inc (OTLK) P/S Ratio is 416.09x based on the latest available daily valuation data on Chartloom.

How to interpret P/S Ratio for Outlook Therapeutics Inc?

Interpreting P/S Ratio for Outlook Therapeutics Inc depends on industry, growth expectations, profitability, and peer multiples.

How do you interpret Price-to-Sales Ratio (P/S)?

High P/S ratios reflect expectations for future margin expansion or rapid growth.

What should investors consider when analyzing Price-to-Sales Ratio (P/S)?

Compare to peers with similar gross-margin profiles.

Free AI scores & summaries library

Outlook Therapeutics Inc

$OTLK

Health Care · Biotechnology

IR Run Scenarios

$0.49

-2.36%

Free AI scores & summaries library

Outlook Therapeutics Inc

$OTLK

Health Care · Biotechnology

IR Run Scenarios

$0.49

-2.36%

Overview AI Summary Charts Financials Valuation

Outlook Therapeutics Inc (OTLK) P/S Ratio: 416.09x

Market cap divided by sales over the last 12 months. Useful for companies that aren’t profitable yet.

Latest P/S Ratio

416.09x

As of Jun 29, 2026

P/S Ratio

All ChartsAll Valuation Charts

Explore Outlook Therapeutics Inc's full valuation history

Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.

View All Valuation Charts

Recent P/S Ratio history

Daily readings for the most recent trading days on record.

Date	P/S Ratio
Jun 29, 2026	416.09x
Jun 26, 2026	421.02x
Jun 25, 2026	396.40x
Jun 24, 2026	413.63x
Jun 23, 2026	418.56x
Jun 22, 2026	450.56x
Jun 18, 2026	389.01x
Jun 17, 2026	406.24x

How is P/S Ratio calculated?